TDMS Study 60855-02 Pathology Tables
NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04 Route: GAVAGE Time: 14:15:11 Facility: BIORELIANCE Chemical CAS #: 7166-19-0 Lock Date: 04/23/92 Cage Range: All Reasons For Removal: All Removal Date Range: All Treatment Groups: Include All a Number of animals examined microscopically at site and number of animals with lesion Page 1 NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04 Route: GAVAGE Time: 14:15:11 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE CONTROL 0.037 0.075 0.150 0.300 0.600 G/KG G/KG G/KG G/KG G/KG ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Dosing Accident 1 Natural Death 6 Moribund Sacrifice 4 Survivors Terminal Sacrifice 10 10 10 9 10 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ Page 2 NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04 Route: GAVAGE Time: 14:15:11 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE FEMALE CONTROL 0.037 0.075 0.150 0.300 0.600 G/KG G/KG G/KG G/KG G/KG ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 3 NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04 Route: GAVAGE Time: 14:15:11 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE CONTROL 0.037 0.075 0.150 0.300 0.600 G/KG G/KG G/KG G/KG G/KG ____________________________________________________________________________________________________________________________________ DISPOSITION SUMMARY Animals Initially in Study 10 10 10 10 10 10 Early Deaths Natural Death 1 4 Moribund Sacrifice 6 Survivors Terminal Sacrifice 9 9 9 10 9 Accidently Killed 1 1 1 Animals Examined Microscopically 10 10 10 10 10 10 ____________________________________________________________________________________________________________________________________ ALIMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ CARDIOVASCULAR SYSTEM None ____________________________________________________________________________________________________________________________________ ENDOCRINE SYSTEM None ____________________________________________________________________________________________________________________________________ GENERAL BODY SYSTEM None ____________________________________________________________________________________________________________________________________ GENITAL SYSTEM None ____________________________________________________________________________________________________________________________________ HEMATOPOIETIC SYSTEM None ____________________________________________________________________________________________________________________________________ Page 4 NTP Experiment-Test: 60855-02 INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (a) Report: PEIRPT02 Study Type: 18-33 DAYS BETA-BROMO-BETA-NITROSTYRENE Date: 10/19/04 Route: GAVAGE Time: 14:15:11 ____________________________________________________________________________________________________________________________________ B6C3F1 MICE MALE CONTROL 0.037 0.075 0.150 0.300 0.600 G/KG G/KG G/KG G/KG G/KG ____________________________________________________________________________________________________________________________________ INTEGUMENTARY SYSTEM None ____________________________________________________________________________________________________________________________________ MUSCULOSKELETAL SYSTEM None ____________________________________________________________________________________________________________________________________ NERVOUS SYSTEM None ____________________________________________________________________________________________________________________________________ RESPIRATORY SYSTEM None ____________________________________________________________________________________________________________________________________ SPECIAL SENSES SYSTEM None ____________________________________________________________________________________________________________________________________ URINARY SYSTEM None Page 5 ------------------------------------------------------------ ---------- END OF REPORT ---------- ------------------------------------------------------------